Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Radiology
|
December 4, 2002
Vertebral metastases: assessment with apparent diffusion coefficient
Andreas M Herneth, Marcel O Philipp, Jonathan Naude, et al.
European Heart Journal. Digital Health
|
January 30, 2023
Utility of mobile learning in Electrocardiography
Charle André Viljoen, Rob Scott Millar, Julian Hoevelmann, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial
Sean Wasserman, Angharad Davis, Cari Stek, et al.
Scientific Reports
|
February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
The Lancet. HIV
|
August 7, 2021
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Waasila Jassat, Cheryl Cohen, Stefano Tempia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial
Angharad G Davis, Sean Wasserman, Cari Stek, et al.
Wellcome Open Research
|
July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]
Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Tropical Medicine & International Health : TM & IH
|
April 12, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies, Reshma Kassanjee, Petro Rosseau, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 27, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies, Erna Morden, Petro Rousseau, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Radiology
|
December 4, 2002
Vertebral metastases: assessment with apparent diffusion coefficient
Andreas M Herneth, Marcel O Philipp, Jonathan Naude, et al.
European Heart Journal. Digital Health
|
January 30, 2023
Utility of mobile learning in Electrocardiography
Charle André Viljoen, Rob Scott Millar, Julian Hoevelmann, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial
Sean Wasserman, Angharad Davis, Cari Stek, et al.
Scientific Reports
|
February 16, 2022
Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial)
Karin van den Berg, Tanya Nadia Glatt, Marion Vermeulen, et al.
The Lancet. HIV
|
August 7, 2021
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Waasila Jassat, Cheryl Cohen, Stefano Tempia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 9, 2022
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial
Angharad G Davis, Sean Wasserman, Cari Stek, et al.
Wellcome Open Research
|
July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]
Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Tropical Medicine & International Health : TM & IH
|
April 12, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies, Reshma Kassanjee, Petro Rousseau, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies, Reshma Kassanjee, Petro Rosseau, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 27, 2022
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
Mary-Ann Davies, Erna Morden, Petro Rousseau, et al.
Page
of 2